An in vitro study of histamine on the pulmonary artery of the Wistar-Kyoto and spontaneously hypertensive rats

European Journal of Pharmacology

Volumn 470, Issue 1-2, 2003, Pages 45-55

  Lau, Wing Hung ^a   Kwan, Yiu Wa ^a   Au, Alice Lai Shan ^a   Cheung, Wui Hang ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

(Wistar Kyoto rat); Histamine; Nitric oxide (NO); Pulmonary artery; Spontaneously hypertensive, rat

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 2,5 PYRROLIDINEDIONE; 3 (3 DIMETHYLAMINOPROPYL) 4 HYDROXY N [4 (4 PYRIDINYL)PHENYL]BENZAMIDE; 6 ANILINO 5,8 QUINOLINEQUINONE; 6 [2 (2 CHLOROPHENYL) 4 (2 HYDROXYPHENYL) 1,3 DIOXAN 5 YL] 4 HEXENOIC ACID; 6 [2 (4 IMIDAZOLYL)ETHYLAMINO] N (4 TRIFLUOROMETHYLPHENYL)HEPTANECARBOXAMIDE; ADENYLATE CYCLASE; AMINE OXIDASE (COPPER CONTAINING); AMINOGUANIDINE; CIMETIDINE; CLOBENPROPIT; DIMAPRIT; DIPHENHYDRAMINE; HISTAMINE; HISTAMINE H1 RECEPTOR AGONIST; HISTAMINE METHYLTRANSFERASE; HISTAMINE RECEPTOR; HOMODIMAPRIT; IMETIT; N (2 PHENYLCYCLOPENTYL)AZACYCLOTRIDECAN 2 IMINE; NITRIC OXIDE; PHENYLEPHRINE; PRAZOSIN; SALBUTAMOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ENDOTHELIUM; ENZYMATIC DEGRADATION; ENZYME ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; RAT; RAT STRAIN; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0038361020     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01759-X     Document Type: Article

References (54)

1. Aharinejad S., Schraufnagel D.E., Bock P., MacKay C.A., Larson E.K., Miksovsky A., Marks S.C. Jr. Spontaneously hypertensive rats develop pulmonary hypertension and hypertrophy of pulmonary venous sphincters. Am. J. Pathol. 148:1996;281-290.
2. Arai M., Chiba S. Endothelium-dependent vasodilatation mechanisms by histamine in simian but not in canine femoral arterial branches. J. Auto. Pharmacol. 19:1999;267-273.
3. 3 receptors regulating acetylcholine release in rat entorhinal cortex. Br. J. Pharmacol. 114:1995;1518-1522.
4. Arunlakshana O., Schild H.O. Some quantitative uses of drug antagonists. Br. J. Pharmacol. 14:1959;48-58.
5. Beavan M.A., Shaff R.E. Inhibition of histamine methylation in vivo by the dimaprit analog, SKF compound 91488. Agents Action. 9:1979;455-460.
6. Bonnet S., Hyvelin J.M., Bonnet P., Marthan R., Savineau J.P. Chronic hypoxia-induced spontaneous and rhythmic contractions in the rat main pulmonary artery. Am. J. Physiol. 281:2001;L183-L192.
7. 3 receptors in the trachea. Br. J. Pharmacol. 111:1994;445-454.
8. Choy W.Y., Wong Y.F., Kwan Y.W., Au A.L.S., Lau W.H., Raymond K., Zuo J.Z. Role of mitogen-activated protein kinase pathway in acetylcholine-mediated in vitro relaxation of rat pulmonary artery. Eur. J. Pharmacol. 434:2002;55-64.
9. Coge F., Guenin S.P., Rique H., Boutin J.A., Galizzi J.P. Structure and expression of the human h4-receptor gene. Biochem. Biophys. Res. Commun. 284:2001;301-309.
10. Douglas J.S., Duncan P.G., Mukhopadhyay A. The antagonism of histamine-induced tracheal and bronchial muscle contraction by diphenhydramine: effect of maturation. Br. J. Pharmacol. 83:1984;697-705.
11. Futo J., Kupferberg J.P., Moss J. Inhibition of histamine N-methyl-transferase (HNMT) in vitro by neuromuscular relaxants. Biochem. Pharmacol. 39:1990;415-420.
12. 3 receptor agonist. J. Pharmacol. Exp. Ther. 263:1992;304-310.
13. Hamada H., Terai M., Kimura H., Hirano K., Oana S., Niimi H. Increased expression of mast cell chymase in the lungs of patients with congenital heart disease associated with early pulmonary vascular disease. Am. J. Respir. Crit. Care Med. 160:1999;1303-1308.
14. Hendriks M.G., Kam K.L., Pijl A.J., Pfaffendorf M., van Zwieten P.A. The effects of hypertension and diabetes mellitus on the vascular reactivity of resistance arteries. Blood Press. 2:1993;69-76.
15. Hill S.J. Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmacol. Rev. 42:1990;45-83.
16. Hill S.J., Ganellin C.R., Timmerman H., Schwartz J.C., Shankley N.P., Young J.M., Schunack W., Levi R., Haas H.L. International union of pharmacology: XIII. Classification of histamine receptors. Pharmacol. Rev. 49:1997;253-278.
17. 3) of histamine receptors on perivascular nerve terminals. Nature. 327:1987;158-160.
18. Jino H., Kurahashi K., Usui H., Nakata Y., Shimizu Y., Temma S. Pharmacological nature of TP receptor mediated contraction in human intrapulmonary artery. Life Sci. 59:1996;2059-2065.
19. Kam K.L., Pfaffendorf M., van Zwieten P.A. Drug-induced endothelium-dependent and -independent relaxations in isolated resistance vessels taken from simultaneously hypertensive and streptozotocin-diabetic rats. Blood Press. 3:1994;418-427.
20. 3 receptor model. Naunyn-Schmiedeberg's. Arch. Pharmacol. 348:1993;498-503.
21. 2 may be the endothelium-derived contracting factor released by acetylcholine in the aorta of the rat. Hypertension. 15:1990;475-481.
22. 2-receptor-mediated nitric oxide release from porcine endothelial cells. J. Cardiovasc. Pharmacol. 32:1998;177-182.
23. Kitanaka J., Kitanaka N., Tsujimura T., Terada N., Takemura M. Expression of diamine oxidase (histaminase) in guinea-pig tissues. Eur. J. Pharmacol. 437:2002;179-185.
24. Krstić M.K., Stepanović R., Ilić K., Krstić S.K. Endothelium-independent contractile and relaxant responses to histamine in the rabbit aorta and common carotid, mesenteric, renal and femoral arteries. Gen. Pharmacol. 27:1996;529-533.
25. Kwan Y.W., To K.W., Lau W.M., Tsang S.H. Comparison of the vascular relaxant effects of ATP-dependent channel openers on aorta and pulmonary artery isolated from spontaneously hypertensive and Wistar-Kyoto rats. Eur. J. Pharmacol. 365:1999;241-251.
26. 3-receptors in the inhibition of cholinergic contractile responses of the guinea pig ileum. J. Pharmacol. Exp. Ther. 295:2000;607-613.
27. Leurs R., Smit M.J., Timmerman H. Molecular pharmacological aspects of histamine receptors. Pharmacol. Ther. 66:1995;413-463.
28. 4) expressed in bone marrow. Mol. Pharmacol. 59:2001;420-426.
29. 4 receptors reveals substantial pharmacological species variation. J. Pharmacol. Exp. Ther. 299:2001;121-130.
30. 1-like receptor-mediated vasoconstriction in human pulmonary artery. Br. J. Pharmacol. 119:1996;277-282.
31. Martinez A.C., Garcia-Sacristan A., Rivera L., Benedito S. Biphasic response to histamine in rabbit penile dorsal artery. J. Cardiovasc. Pharmacol. 36:2000;737-743.
32. Matsuda K., Sekiguchi F., Yamamoto K., Shimamura K., Sunano S. Unaltered endothelium-dependent modulation of contraction in the pulmonary artery of hypertensive rats. Eur. J. Pharmacol. 392:2000;61-70.
33. McLean J.R., Twarog B.M., Bergofsky E.H. The adrenergic innervation of pulmonary vasculature in the normal and pulmonary hypertensive rat. J. Auton. Nerv. Syst. 14:1985;111-123.
34. 3 receptors. Naunyn-Schmiedeberg's. Arch. Pharmacol. 346:1992;46-50.
35. 2 receptors. Eur. J. Pharmacol. 338:1997;135-141.
36. 3 receptor: gene organization and multiple isoforms. Biochem. Biophys. Res. Commun. 280:2001;75-80.
37. Nakamura T., Itadani H., Hidaka Y., Ohta M., Tanaka K. Molecular cloning and characterization of a new human histamine receptor, HH4R. Biochem. Biophys. Res. Commun. 279:2000;615-620.
38. Nguyen T., Shapiro D.A., George S.R., Setola V., Lee D.K., Cheng R., Rauser L., Lee S.P., Lynch K.R., Roth B.L., O'Dowd B.F. Discovery of a novel member of the histamine receptor family. Mol. Pharmacol. 59:2001;427-433.
39. 4 receptor. Biochim. Biophys. Acta. 1575:2002;135-138.
40. Ortiz J.L., Labat C., Norel X., Gorenne I., Verley J., Brink C. Histamine receptors on human isolated pulmonary arterial muscle preparations: effects of endothelial cell removal and nitric oxide inhibitors. J. Pharmacol. Exp. Ther. 260:1992;762-767.
41. Pulido E.J., Shames B.D., Fullerton D.A., Sheridan B.C., Selzman C.H., Gamboni-Robertson F., Bensard D.D., McIntyre R.C. Jr. Differential inducible nitric oxide synthase expression in systemic and pulmonary vessels after endotoxin. Am. J. Physiol. 278:2000;R1232-R1239.
42. 3 receptors in isolated guinea pig pulmonary artery and ileum. Eur. J. Pharmacol. 294:1995;329-335.
43. Russell P.C., Wright C.E., Barer G.R., Howard P. Histamine induced pulmonary vasodilatation in the rat: site of action and changes in chronic hypoxia. Eur. Respir. J. 7:1994;1138-1144.
44. 2-adrenoceptor activation in rat aortic rings. Br. J. Pharmacol. 119:1996;505-510.
45. Satoh H., Inui J. Endothelial cell-dependent relaxation and contraction induced by histamine in the isolated guinea-pig pulmonary artery. Eur. J. Pharmacol. 97:1984;321-324.
46. Schayer R.W. Catabolism of physiological quantities of histamine in vivo. Physiol. Rev. 39:1959;116-120.
47. 3 receptor heterogeneity? Naunyn-Schmiedeberg's. Arch. Pharmacol. 353:1996;482-488.
48. Tamura H., Horiike K., Fukuda H., Watanabe T. Kinetic studies on the inhibition mechanism of diamine oxidase from porcine kidney by aminoguanidine. J. Biochem. 105:1989;299-306.
49. Török J. Histamine-induced relaxation in pulmonary artery of normotensive and hypertensive rats: relative contribution of prostanoids, nitric oxide and hyperpolarization. Physiol. Res. 49:2000;107-114.
50. Trippodo N.C., Frohlich E.D. Similarities of genetic (Spontaneous) hypertension. Circulation. 48:1981;309-319.
51. 3 receptors in human saphenous vein and guinea pig ileum. Eur. J. Pharmacol. 366:1999;73-78.
52. Van de Voorde J., Delaey C., Depypere H., Vanheel B. Mechanisms involved in the vasorelaxing influence of histamine on isolated human subcutaneous arteries. Eur. J. Pharmacol. 349:1998;61-66.
53. 3 receptor activation inhibitis neurogenic sympathetic vasoconstriction in porcine nasal mucosa. Eur. J. Pharmacol. 452:2002;339-345.
54. Zhu Y., Michalovich D., Wu H.L., Tan K.B., Dytko G.M., Mannan I.J., Boyce R., Alston J., Tierney L.A., Li X.T., Herrity N.C., Vawter L., Sarau H.M., Ames R.S., Davenport C.M., Hieble J.P., Wilson S., Bergsma D.J., Fitzgerald L.R. Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Mol. Pharmacol. 59:2001;434-441.